Request Deal Involvement
Oceanpine and OrbiMed co-led the $130m Series B funding round for Yisheng Biopharma.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
CEC Capital
legal advisors
Wilson Sonsini Goodrich & Rosati
legal advisors
Tian Yuan Law Firm
legal advisors
Sidley Austin
legal advisors
Han Kun Law Offices
or
Principals
bidder
ADJUVANT CAPITAL
target
YISHENG BIOPHARMA
bidder
EIGHTROAD
bidder
ORBIMED ADVISORS LLC
bidder
3W CAPITAL
bidder
OCEANPINE CAPITAL
bidder
AIHC CAPITAL
bidder
SUPERSTRING CAPITAL
bidder
F-PRIME CAPITAL
bidder
MSA CAPITAL
bidder
HILLHOUSE CAPITAL GROUP
bidder
EPIPHRON CAPITAL
bidder
HAITONG INNOVATION CAPITAL MANAGEMENT
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite